Introduction {#S1}
============

Wolf--Hirschhorn syndrome (WHS) is a developmental disorder characterized by craniofacial malformations, intellectual disability, microcephaly, seizures, growth retardation, and developmental delays, though the severity of these symptoms varies from patient to patient ([@B39]; [@B48]; [@B96]; [@B3]; [@B91]). The core phenotype of WHS is the "Greek warrior helmet" appearance, defined by a prominent forehead, widely spaced eyes (hypertelorism), and an unusually wide and protrusive nasal bridge ([@B34]). Other craniofacial abnormalities include an undersized jaw (micrognathia), a short philtrum, and cleft lip ([@B34]). Most patients present with microcephaly and, less frequently, with skeletal defects, renal and urogenital defects, heart defects, hearing loss, and ocular irregularities ([@B2]; [@B87]).

The chromosomal basis of WHS has been linked to a telomeric heterozygous microdeletion on the short arm of chromosome 4, though the nature and size of this deletion differs between patients ([@B119]; [@B3]; [@B7]). The central phenotypes of WHS are most strongly associated with the deletion of two adjacent, non-overlapping critical regions at 4p16.3, WHS critical region 1 (WHSCR1) and WHS critical region 2 (WHSCR2) ([@B3]). These regions are comprised of the primary candidate genes WHSC1, WHSC2, and LETM1 ([Figure 1](#F1){ref-type="fig"}; [@B3]; [@B21]). However, most WHS patients harbor mutations that extend beyond these critical regions, affecting several flanking genes such as TACC3, FGFR3, SLBP, CTBP1, CPLX1, PIGG, MSX1, and FGFRL1, demonstrating that deletions encompassing these genes may also contribute to the presentation of WHS symptoms ([@B48]; [@B33]; [@B3]; [@B52]; [@B91]).

![Chromosome 4 and WHS-associated genes. All genes are represented in their order from left to right, telomeric to centromeric orientation, located on the distal arm of chromosome 4p16.3. Brackets delineate WHS critical region 1 (WHSCR1), comprised of *LETM1* and *WHSC1*, and WHS critical region 2 (WHSCR2), comprised of *WHSC1* and *WHSC2*. Genes that are also mutated in WHS patients consist of *PIGG*, *CPLX1*, *FGFRL1*, *CTBP1*, *SLBP*, *TACC3*, and *FGFR3*, which flank the WHS critical regions.](fphys-10-00817-g001){#F1}

Due to the clinical and genetic variability of WHS, the pathology underlying the disorder has been difficult to determine. However, the characteristic facial and cardiac phenotypes of WHS suggest a particular cell population may be affected by mutations of WHS-associated genes. Vertebrate facial features are derived from or influenced by neural crest cells (NCCs), which are a group of multipotent stem cells that are born along the neural tube and migrate long distances toward their final destination ([@B71]). Additionally, some WHS-associated genes have defined roles in epigenetic modifications or signaling pathways that are integral for proper embryonic development and cell-motility related processes ([@B91]). Therefore, it is possible that some of the developmental defects associated with WHS may be due to abnormalities in signaling pathways that affect NCC motility or migration.

While some animal models of WHS do exist, most of these studies have focused on the cellular and molecular functions of singular WHS-associated genes, specifically WHSC1 and LETM1 ([@B3]). However, the link between haploinsufficiency of most WHS-associated genes to specific vertebrate developmental processes such as brain, craniofacial, and heart development, has not been carefully examined. Furthermore, clinical studies of WHS patients have provided clear evidence that the syndrome is multigenic ([@B3]); yet, we still lack a mechanistic understanding of how the depletion of WHS-associated genes combinatorially contributes to the phenotypic spectrum of the disorder.

The model organism, *Xenopus laevis*, has been used extensively in the research community for decades to examine fundamental developmental and cellular biological processes, making it an ideal system for investigating human genetic disorders, such as WHS. *X. laevis* offers a number of benefits, as they are inexpensive and easy to culture, maintain, manipulate, and image, compared to other vertebrates ([@B36]; [@B100]). Thus, *Xenopus* is well-suited to examine the role of WHS-associated genes during vertebrate development, and can be used to test whether abnormal NCC migration may be one mechanism by which mutations of these genes contribute to phenotypes of the disease.

In this review, we provide a brief overview of the known functions of WHS-associated genes and how they may be linked to developmental processes, such as NCC migration. We also highlight how *Xenopus* is an advantageous system to study WHS as a multigenic disorder, and we discuss ways in which it can be used to investigate how WHS-associated genes individually and combinatorially affect both proper embryonic development and the phenotypes linked to WHS.

WHS Critical Region and Associated Candidate Genes {#S2}
==================================================

Wolf--Hirschhorn syndrome is a contiguous gene syndrome associated with small heterozygous deletions of the 4p chromosomal region. Following the initial characterization of the disorder in the 1960s, research has focused on generating a consensus of the core WHS phenotype, which includes intellectual disability, growth delay, seizures, and the typical craniofacial dysmorphisms, as well as defining the critical genomic region that gives rise to this core phenotype ([@B3]). The first critical region to be described, WHSCR1, consisted of a small 165 kb region encompassing two candidate genes, WHS Candidates 1 and 2 (WHSC1, WHSC2), and is deleted in all traditional cases of the disorder ([@B3]).

However, further clinical studies of children with WHS detected an even larger 1.9 Mb deletion that extends distally beyond WHSCR1, sufficient to produce the full WHS core phenotype ([@B3]). This newly described region is referred to as WHSCR2 and encompasses a more telomeric region of WHSC1, as well as a new candidate gene, leucine zipper and EF-hand containing transmembrane protein 1 (LETM1) ([@B3]). Moreover, many WHS patients harbor mutations of genes that flank these critical regions, providing increasing evidence that the manifestation of the disorder is not due to a single gene, but rather due to the haploinsufficiency of several closely linked genes ([@B3]; [@B91]). Thus, WHS is largely considered to be a true multigenic disorder. In the subsequent sections, we describe the current known functions of the primary WHS candidate genes, as well as other WHS-associated genes, their potential roles during embryonic development, and how they may contribute to the spectrum of WHS phenotypes.

WHSC1 {#S2.SS1}
-----

WHSC1 is a histone methyltransferase, belonging to a family of nuclear receptor SET domain (NSD) proteins that possess a SET domain encoding lysine melthyltransferase activity ([@B85]; [@B37]; [@B66]). Specifically, WHSC1 is associated with trimethylation of histone H3K36, a mark that is highly correlated with active transcription. WHSC1 is partially or fully deleted in nearly all cases of WHS and is thought to be responsible for many of the core WHS phenotypes, including growth delay and facial irregularities ([@B2]; [@B3]; [@B9]; [@B21]); yet, the mechanism behind which its depletion leads to these phenotypes remains to be elucidated.

The spatial and temporal expression of WHSC1, as well as its transcriptional regulation activity, suggests that it plays an important role during development ([@B91]). WHSC1 is a known regulator of TWIST, a key player in both the epithelial-to-mesenchymal transition (EMT) and cell migration ([@B37]). Moreover, WHSC1 is expressed in the developing nervous system, pharyngeal arches, and frontal facial region in both mice and *Xenopus laevis*, as well as jaw and heart in mice ([@B102]; [@B85]; [@B114]; [@B66]; [@B75]), which is significant, given that many of these structures are both derived from the neural crest and are affected in WHS.

However, until recently, WHSC1 function had not been directly associated with NCC migration. To gain further insight into the role of WHSC1, specifically during processes that govern craniofacial morphogenesis, [@B75] sought to observe the effects of reducing WHSC1 dosage levels in *Xenopus laevis* during embryonic development. They found that WHSC1 KD results in reduced length and area of the pharyngeal arches, as well as reduced NCC migration speed. Depletion of WHSC1 also causes severe craniofacial and brain morphology defects including widening of the facial width and area, and reduction of forebrain size. Together, these results are the first to demonstrate that reduced levels of WHSC1 cause aberrant NCC migration, which may lead to some of the craniofacial abnormalities seen in WHS patients. These results are consistent with other studies showing that WHSC1 depletion leads to irregularities in brain, cartilage, and bone formation, specifically incomplete motor neuron development in zebrafish, deficiencies in midline fusion and cleft palate in mice, as well as delayed bone ossification in both zebrafish and mice ([@B85]; [@B114]; [@B37]; [@B66]), indicating a conserved developmental role for WHSC1 among various species.

An important question still remains as to which signaling pathways are affected by WHSC1 reduction and how they contribute to abnormal NCC migratory patterns and WHS phenotypes. A promising possibility is the Wnt signaling pathway, which has already been connected to WHSC1 dysregulation in the context of cancer ([@B110]). [@B110] suggests that WHSC1 dosage may impact canonical Wnt signaling by affecting nuclear levels of beta-catenin through transcriptional regulation. Moreover, in *Xenopus*, canonical Wnt signaling has been shown to be important for NCC specification and migration during development, as well as subsequent craniofacial morphogenesis ([@B68]; [@B64]). Thus, further experiments are necessary to examine whether alterations in WHSC1 dosage impact the Wnt signaling pathway, potentially leading to abnormal NCC migration and the spectrum of defects observed in WHS.

WHSC2 {#S2.SS2}
-----

The WHSC2 gene, also known as NELF-A, encodes a component of the negative elongation factor complex, which negatively regulates RNA polymerase II progression during elongation, subsequently altering the expression of its target genes ([@B60]). Though WHSC2 is commonly deleted in most WHS patients, it has not emerged as a primary contributor to any specific WHS phenotype ([@B3]). However, the cellular and molecular roles of WHSC2 have begun to be illuminated and functionally linked to other WHS-affected genes.

Depletion of WHSC2 in both cell culture and in *Drosophila* has been shown to reduce cellular proliferation and lead to irregularities in cell cycle progression ([@B45]; [@B115]). Interestingly in breast cancer cell lines, reduction of the NELF-E component of the NELF complex is associated with lower levels of trimethylated H3K36 on promoters of NELF-regulated genes ([@B103]). As previously mentioned, levels of trimethylated H3K36 are influenced by the activity of WHSC1, highlighting a potential link between WHSC1 and WHSC2 (NELF-A) in altering gene expression, although this remains to be examined.

WHSC2 also functions to recruit stem-loop binding protein (SLBP) to the 3′ ends of histone pre-mRNAs ([@B82]). SLBP lies telomeric to WHSC2 and mutations of this gene have been found in some WHS patients, though the functional impact of SLBP haploinsufficiency is unclear. SLBP is critical for the correct processing of histone pre-mRNAs and regulating histone degradation. Histone biogenesis is essential for epigenetic gene regulation through histone post-translational modifications and maintenance of chromatin structure ([@B70]). Thus, it is possible that there is a functional connection between WHSC1, WHSC2, and SLBP, and reduced activity of these genes may have impacts on histone levels and transcriptional regulation, which could adversely affect normal development in the context of WHS.

Until recently, WHSC2 function during vertebrate tissue and organ development had not been carefully studied. [@B75] found that WHSC2 expression in *Xenopus* is enriched in the developing nervous system, pharyngeal arches, and frontal facial region. Additionally, altered levels of WHSC2 lead to abnormalities in craniofacial, cartilage, and brain development. Specifically, reduction of WHSC2 causes smaller facial width and area, smaller cartilage elements, as well as smaller brain size ([@B75]), indicating that WHSC2 may play a larger role regarding WHS phenotypes than what was previously thought. It is possible that these phenotypes arise as a consequence of decreased cellular proliferation, as WHSC2 has already been linked to this process ([@B103]), though this connection still needs to be tested. Moreover, it would be interesting to examine whether reduced dosage levels of WHSC2 in combination with WHSC1 or SLBP enhances these phenotypes, providing further evidence that these genes are functionally linked to one another.

LETM1 {#S2.SS3}
-----

LETM1 is localized to the inner mitochondrial membrane and is important for maintaining normal mitochondrial function by participating in Ca^2+^/H^+^ exchange and regulating Ca^2+^ homeostasis within the matrix ([@B27]; [@B57]). LETM1 has been proposed as the candidate gene for seizures in WHS patients ([@B32]; [@B73]; [@B2]; [@B3]). Heterozygous deletion of LETM1 in mice led to altered glucose metabolism and impaired control of ATP levels in the brain, which could explain the increased susceptibility to seizures observed in these animals ([@B57]). However, some WHS patients with LETM1 deletions lack seizures and conversely, some WHS patients have seizures, yet have no detectable mutations in LETM1 ([@B3]). Therefore, it is likely that LETM1 is not solely responsible for the occurrence of seizures and that deletion of additional genes are required for the full expression of the phenotype.

In *Xenopus*, LETM1 is expressed ubiquitously during early embryonic development. As development progresses, more defined expression is observed in the pharyngeal arches, craniofacial and brain regions ([@B75]). Reduced dosage of LETM1 in *Xenopus* revealed that it is critical for proper craniofacial morphology and may contribute to some of the facial defects associated with WHS, which had not been previously demonstrated ([@B75]). Interestingly, knocking down LETM1 did not have a significant effect on NCC migration or motility, which is surprising, given the robust craniofacial phenotype observed. However, it is possible that LETM1 may play an entirely different role in these cells. Proper mitochondrial function and regulation of energy metabolism is critical for determining cell fate and maintaining cell survival ([@B61]). Therefore, while reduced dosage of LETM1 may not directly affect NCC migration, it may greatly impact the metabolic homeostasis of NCCs and lead to downstream effects on differentiation, proliferation, or apoptosis during craniofacial morphogenesis. As LETM1 depletion in fibroblasts derived from WHS patients has already been associated with decreased cellular proliferation ([@B28]), this seems a promising avenue of future research to understand the precise molecular mechanisms of LETM1 involvement in the pathogenesis of WHS.

Additional WHS-Associated Genes {#S2.SS4}
-------------------------------

While all WHS patients harbor full or partial deletions of the WHSCRs, most have mutations that affect multiple genes flanking these regions. It is widely accepted that haploinsufficiency of the WHS critical region genes alone cannot account for the full spectrum of WHS phenotypes ([@B3]). Thus, it is likely that these flanking genes, including TACC3, FGFR3, FGFRL1, SLBP, CTBP1, CPLX1, and PIGG, and MSX1 also contribute to WHS in some capacity.

Fibroblast growth factor receptor 3 (FGFR3) and fibroblast growth factor receptor like 1 (FGFRL1) are both involved in signaling pathways that influence cell division and differentiation. Both FGFR3 and FGFRL1 have been proposed as candidate genes responsible for the skeletal and craniofacial malformations of WHS patients ([@B3]). Homozygous null mouse lines for Fgfrl1 recapitulate many WHS phenotypes such as hypoplasia of skeletal elements, delayed fusion and bone ossification, abnormal forebrain development, and congenital heart defects (CHD) ([@B16]). Conversely, Fgfr3 null mice display severe kyphosis, abnormally long tails and femurs, which is indicative of prolonged bone growth ([@B97]). With opposing phenotypes, it is possible that these two genes antagonize each other to regulate chondrocyte proliferation and may genetically interact to control bone growth. Moreover, FGFR3 has been shown to directly affect NCC migration in chick, with its loss leading to slower NCC migration velocity and increased neural crest death close to the neural tube ([@B92]). However, it remains unclear whether the loss of either FGFR3 or FGFRL1 is directly linked to abnormal NCC migration in the WHS phenotypes.

Transforming acidic coiled-coil protein 3 (TACC3) is a microtubule plus-end tracking (+TIP) protein that resides on the end of polymerizing microtubules and has been shown to regulate microtubule dynamics during neural development ([@B86]; [@B4]; [@B15]; [@B35]). The ways in which TACC3 dosage levels affect gross morphological phenotypes reflected in WHS patients was recently examined and provides a strong link to abnormal NCC migration. In *Xenopus*, TACC3 expression is enriched in the pharyngeal arches, as well as the frontal brain and facial regions ([@B75]). Knockdown of TACC3 led to overt craniofacial and cartilage defects, including smaller facial width, area and angle, which are likely due to overall smaller cartilage elements ([@B75]). Furthermore, *in vivo* migration of NCCs was affected as a consequence of reduced TACC3 levels. This manipulation also severely affected forebrain development, reflecting the microcephaly phenotype commonly associated with WHS. This is interesting given that TACC3 is also known to be an essential centrosome adaptor that is critical for proper cell division, and almost all microcephaly associated genetic defects involve proteins that maintain centrosomes and regulate the mitotic spindle ([@B88]; [@B62]). Thus, it is likely that TACC3 contributes to some WHS phenotypes, possibly by adversely altering the mitotic spindle such that it has downstream effects that influence cell fate and cell migration.

It has been suggested that C-terminal binding protein 1 (CTBP1), complexin 1 (CPLX1), and phosphatidylinositol glycan anchor biosynthesis class G (PIGG) are possible candidates for developmental delay, intellectual disabilities, and seizures in WHS patients ([@B119]). CTBP1 is a transcriptional co-repressor known to mediate E-cadherin repression and play a key role in EMT ([@B117]). Increased Ctbp activity has been shown to reduce epileptic behavior in rats following a ketogenic diet by forcing energy production via the TCA cycle and oxidation of NADH ([@B42]). Reduced levels of NADH stimulates Ctbp activity and could be a mechanism by which loss of CTBP1 contributes to seizures. Ctbp1 mutant mice also exhibit defects in skeletal and muscle development ([@B51]). As CTBP1 is known to be involved in EMT ([@B117]), it seems plausible that mutations of this gene may result in these phenotypes by influencing NCC migration.

CPLX1 is a cytosolic protein that is important for synaptic vesicle exocytosis and regulation of neurotransmitter release ([@B46]). Mutations of CPLX1 have been associated with epilepsy and intellectual disability, and Cplx1 knockout mice exhibit pronounced motor and social deficits ([@B46]; [@B29]; [@B90]). Pathogenic variants of PIGG are associated with intellectual disability, hypotonia, and seizures ([@B69]). PIGG localizes to the endoplasmic reticulum and is responsible for the biogenesis of GPI anchor proteins in zebrafish, which is critical for expression of voltage-gated sodium channels in a subset of neurons ([@B80]). However, it is clear that further research is needed to determine how these genes are distinctly contributing to the development of organs and tissues that are affected in WHS.

MSX1 (Msh homeobox 1) functions as a transcriptional repressor during embryogenesis and has been suggested as a candidate gene for the oral and dental malformations seen in some WHS patients ([@B83]). Mutations of MSX1 have been associated with non-syndromic cleft palate and tooth agenesis in humans, and Msx1-deficient mice exhibit severe craniofacial abnormalities, cleft palate, and absence of teeth ([@B93]; [@B118]; [@B83]). In *Xenopus*, MSX1 has been shown to be critical for NCC induction and regulates the expression of genes that are necessary for proper NCC migration ([@B77]; [@B10]; [@B67]). Thus, it is likely that haploinsufficiency of MSX1 contributes to some craniofacial and dental defects associated with WHS by affecting NCC induction, as well as having downstream regulatory effects on genes that influence their subsequent migration.

Using *Xenopus Laevis* as a Model to Study WHS {#S3}
==============================================

In an effort to answer some outstanding questions regarding the pathogenesis of WHS, it is critical to choose a model organism that is ideal for studying human genetic diseases. Every model system has its benefits and limitations; however, *X. laevis* has emerged as a particularly advantageous model for studying human genetic diseases, like WHS. While mouse models are an excellent mammalian system due to the similarity between the mouse and human genomes and the large genetic toolkit available, they are very costly to house and maintain. Moreover, litter sizes are small, embryonic development occurs *in utero*, and creating genetic lines that harbor mutant alleles is time-consuming. While zebrafish produce many offspring and have well-developed genetic manipulation strategies, their genome has lost a great deal of synteny with mammals and many relevant disease-related genes do not perform the same function ([@B40]). Zebrafish also lack organ systems, such as limbs, digits, and lungs, that are involved in many human congenital syndromes. Additionally, the zebrafish heart only has one atrium and one ventricle, and cannot fully model developmental heart abnormalities, like those associated with WHS.

However, using *Xenopus* as a system to investigate human genetic diseases of development has enormous potential, and can complement more established systems, like mouse or zebrafish, to enhance our knowledge about the function of understudied genes and the underlying mechanisms by which developmental abnormalities arise. In the following sections, we highlight why *X. laevis* is an advantageous model to choose for investigating developmental disorders, with a specific focus on how it can be used to examine multiple aspects of WHS.

Advantages of *Xenopus laevis* as a Model Organism {#S3.SS1}
--------------------------------------------------

*Xenopus* is an excellent system for relatively high throughput analysis of genetic manipulation on vertebrate embryonic development. *Xenopus* shares a high degree of synteny with humans and a majority of disease-associated genes are conserved between these species ([@B49]; [@B94]). Despite *X. laevis* having a duplicated genome, genetic manipulation strategies can still be utilized. However, *X. tropicalis* may be more suitable, depending on the number of genes being studied, as they are diploid, making genetic manipulation much easier and more rapid. The *Xenopus* genome is widely available to the research community through the efforts of *Xenbase*, an online resource that has organized current annotated genetic information, protocols, *Xenopus* anatomy and development, scientific literature, and provides useful sequencing tools, such as the genome browser and *Xenopus* specific BLAST ([@B56]).

A key characteristic of the *Xenopus* model is the ease of acquiring large amounts of high quality embryos by inducing females to lay eggs via hormone priming ([@B98], [@B99]; [@B36]; [@B100]). Hundreds of embryos can be obtained in a single clutch, enabling numerous embryos to be manipulated and observed in a single experiment. *Xenopus* development occurs rapidly and externally, with gastrulation and neurulation occurring between 9 and 26 h post fertilization, and organogenesis almost complete by 5 days post fertilization ([@B84]; [@B116]). *Xenopus* organ development and morphology have been well-characterized and is comparable to those of mammalian systems, including orofacial ([@B25]), heart ([@B50]), kidney ([@B44]), and nervous system development ([@B89]; [@B63]), all of which are affected in WHS patients. Moreover, *Xenopus* is being used extensively as a model to understand a number of different human genetic diseases that lead to defects in these systems, such as congenital heart disorders ([@B12]; [@B101]; [@B31]; [@B20]), kidney disease ([@B65]), ciliopathies ([@B14]; [@B111]), orofacial defects ([@B105]; [@B25]), and neurodevelopmental disorders ([@B89]; [@B106]; [@B113]).

In order to characterize WHS-associated gene functions in relation to development and disease, *Xenopus* embryos can be injected with a variety of materials to manipulate gene expression, such as CRISPR/cas9 or morpholino oligonucleotides (MOs), in either the whole embryo or selected blastomeres (up to the 64-cell stage) ([@B76]; [@B107], [@B106]; [@B5]; [@B6]; [@B112]; [@B19]; [@B38]; [@B78], [@B79]). As the lineage of individual cells has been well-documented, injections can be precisely targeted to specific tissues and organs that are affected in WHS, such as the heart, kidney, or brain. A unique feature of *Xenopus* compared to other models is the ability to perform one-sided embryo injections, wherein only one side of the embryo is experimentally manipulated and the opposite side serves as an internal control ([Figure 2](#F2){ref-type="fig"}; [@B113]; [@B75]). Thus, assessing phenotypic consequences that arise as a result of genetic manipulation can be compared side-by-side to wild-type gene expression.

![*Xenopus* one-sided injections allow for side-by-side comparison to wild-type gene expression following genetic manipulation. **(A)** *Xenopus* embryos can be injected in one cell at the 2-cell stage with genetic manipulation macromolecules and fluorescent mRNA. At stage 21, embryos can be sorted depending on the side that was injected (left vs. right) and used for various assays throughout development. **(B)** Representative image of stage 47 *X. laevis* tadpole immunolabeled for acetylated tubulin. Asterisk represents the side that was injected with MO and fluorescent mRNA. Brain morphology, such as forebrain size (red outline), midbrain size (yellow outline), and hindbrain size (orange outline), of the manipulated side can be compared to the unaltered, wild-type side. Scale bar: 500 μm.](fphys-10-00817-g002){#F2}

Morpholino oligonucleotides are particularly useful in modeling genetic diseases, like WHS, as they can be easily titrated to reduce gene dosage levels similar to that in human patients ([@B105]; [@B8]; [@B72]). Because WHS-associated mutations result in haploinsufficiency, a full knockout of the candidate genes would not appropriately model the disease, and simultaneous knockdown of genes can be achieved by injecting multiple MOs at once, allowing for concurrent knockdown of genes that are often deleted together in WHS ([@B8]). While it is certainly possible to produce mouse lines with mutations in multiple genes ([@B97]), this is a costlier and more time-consuming process than the equivalent in *X. laevis.* As with all manipulation strategies, the appropriate controls must be used to account for off-target effects, such as generating more than one MO, dose dependency, and rescuing phenotypes by co-injecting mRNA that is not targeted by the MO ([@B8]; [@B43]).

The CRISPR/cas9 system has also been used as an extremely effective method to knock out target genes in both *X. tropicalis* and *X. laevis* ([@B6]; [@B112]; [@B106]). While the off-target effects of CRISPR/cas9 are generally minimal, the use of proper controls is critical by carefully designing multiple sgRNAs and performing rescue experiments to confirm that any phenotypes observed are due to the knockout of a particular gene ([@B81]; [@B112]). The CRISPR/cas9 system can be employed to validate phenotypes that arise as a result of MO-mediated gene knockdown by comparing phenotypes generated by both methods ([@B6]; [@B113]). Overall, *Xenopus* is an excellent system for investigating developmental disorders, such as WHS, and for elucidating the mechanism by which manipulation of WHS-associated genes alters proper embryonic development.

*Xenopus laevis* as a Model for Studying Neural Crest Cell Migration {#S3.SS2}
--------------------------------------------------------------------

As the underlying cellular and molecular mechanisms that cause WHS are unknown, it is essential to investigate the basis behind the disorder. One particularly promising avenue of research in this regard is the migration of the NCC population in the developing embryo ([@B91]). As stated previously, NCCs are a multipotent stem cell population that originate along the neural tube, delaminate, and migrate throughout the developing embryo to their final destinations. Once at their proper locations, NCCs differentiate and contribute to various tissues and organ systems, including craniofacial cartilage and bone, smooth muscle of the heart, peripheral and enteric neurons, melanocytes, and glia ([@B13]). Considering craniofacial abnormalities are one of the defining phenotypes of WHS, the link to potential aberrations in NCC migration is strong. Moreover, almost all WHS-associated genes are connected with NCC migration or signaling pathways that may influence NCC differentiation or proliferation in some capacity. Therefore, research into NCC migration in relation to WHS is of great interest.

*Xenopus laevis* is an ideal model organism for studying NCC migration, as both *in vivo* and *in vitro* NCC migration can be tracked through multiple methods. NCC migration can be observed *in vivo* by performing transplantation assays, whereby NCCs are dissected from GFP-injected *Xenopus* embryos and transplanted to wild-type host embryos ([@B11]; [@B17]). These embryos can then be imaged using time-lapse confocal microscopy and NCC migration can be analyzed by measuring the number, width, and migration distance of the GFP-marked cranial segments. Additionally, two transgenic *X. laevis* frog lines, PAX3-GFP and SOX10-GFP, are available through the National *Xenopus* Resource (NXR) to study the *in vivo* development and migration of NCCs ([@B1]). *In vivo* NCC migration can also be analyzed through whole-mount *in situ* hybridization by observing the morphology of the pharyngeal arches using a marker for NCCs, such as TWIST or SOX9 ([Figure 3](#F3){ref-type="fig"}; [@B23]; [@B104]).

![Analysis of *in vivo* NCC migration using whole-mount *in situ* hybridization. Representative image of stage 30 *X. laevis* embryo labeled for xTWIST, a marker for NCCs. Measurements of the length (orange line) and area (red dotted line) of each individual pharyngeal arch can be done using ImageJ. Pharyngeal arch length is measured from the most dorsal point to the most ventral point of each individual arch. Pharyngeal arch area is measured as the area around the periphery of each individual arch. cg, cement gland; pa, pharyngeal arches. Scale bar: 500 μm.](fphys-10-00817-g003){#F3}

Neural crest cell motility can be examined *in vitro* by dissecting NCCs from stage 16 *Xenopus* embryos and culturing explants on fibronectin-coated coverslips ([@B18]). Migratory behavior of NCC explants can be observed using time-lapse confocal microscopy and multiple parameters of migration can be measured including velocity and dispersion ([@B22]; [@B74]; [@B18]). Moreover, chemotaxis assays can be performed *in vitro* to assess the directional migration of NCCs toward an external, soluble factor by coating beads with a chemoattractant cue, such as SDF-1 ([@B108]; [@B109]; [@B95]; [@B104]). Recently, these methods were successfully used in *X. laevis* to test whether knockdown of particular WHS genes led to changes in NCC migration both *in vivo* and *in vitro* ([@B75]), demonstrating how *X. laevis* can provide a unique and varied approach to study how alterations in NCC migratory behavior may contribute to phenotypes of the disease.

*Xenopus laevis* as a Model for Studying Other Aspects of WHS {#S3.SS3}
-------------------------------------------------------------

Craniofacial abnormalities are one of the defining phenotypes of WHS and *X. laevis* has emerged as an excellent system for determining which WHS-associated genes are important for craniofacial morphogenesis. As orofacial development is highly conserved between *Xenopus* and other mammalian species, craniofacial abnormalities in *Xenopus* often resemble phenotypes present in human patients ([@B24], [@B26]; [@B105]; [@B30]). Various techniques to assess changes in *Xenopus* orofacial development have already been developed and used to study craniofacial defects associated with human genetic disorders ([@B105]; [@B47]; [@B75]). Similar to NCC transplant assays, facial transplant assays can be performed in *Xenopus* ([@B55]; [@B54]; [@B53]; [@B47]). This technique allows for the examination of gene or protein function in particular cell types involved in facial development, eliminating non-specific effects in the whole embryo, and can be used to study signaling mechanisms or mechanical forces that are involved in orofacial development ([@B25]).

More robust quantitative methods to examine alterations of orofacial development have also been adapted for use in *Xenopus*. Measurements of various craniofacial features such as facial width, height, angle, and area can be done on embryos at different developmental stages using ImageJ ([Figure 4](#F4){ref-type="fig"}; [@B58]; [@B105]). These measurements can be combined with geometric morphometrics in order to detect subtle differences in face shape and size throughout development ([@B59]; [@B25]). Furthermore, techniques for visualizing cartilage morphology, such as Alcian blue staining, can be used to determine whether craniofacial abnormalities arise as a result of defects in cartilage development ([Figure 5](#F5){ref-type="fig"}; [@B105]; [@B23]).

![Measurements of *Xenopus* craniofacial features. **(A)** Representative frontal view image of stage 42 *X. laevis* tadpole. Measurements of facial features include facial height (blue line), facial width (orange line), facial area (red dotted line), facial angle (green line), and mouth roundness (yellow dotted line). Facial height is measured from the top of the middle of the eyes to the top of the cement gland. Facial width is measured from the middle of one eye to the middle of the opposite eye. Facial area is measured as the area around the top of the eyes to the top of the cement gland. Facial angle is measured as the angle between the middle of the eyes and the top of the cement gland. Mouth roundness is measured as the area around the periphery of the mouth. **(B)** Representative lateral view image of stage 42 *X. laevis* tadpole. Measurements of facial features include eye area (red dotted line) and snout length (orange line). Eye area is measured as the area around the periphery of the eye. Snout length is measured from the most anterior part of the face to the bottom of the eye. All measurements can be performed using ImageJ. cg, cement gland. Scale bar: 100 μm.](fphys-10-00817-g004){#F4}

![Measurements of *Xenopus* cartilage elements. **(A)** *Xenopus* cartilage anatomy with all major cartilage elements labeled in various colors. **(B)** Representative ventral view image of stage 45 *X. laevis* tadpole stained for Alcian blue. Measurements of cartilage elements include branchial arch length (orange line) and ceratohyal area (red dotted line), which can be performed using ImageJ. Scale bar: 300 μm.](fphys-10-00817-g005){#F5}

It is important to note that there are some craniofacial and cartilage morphological differences between *Xenopus* and humans that will prevent some direct correlations to disease pathology. For example, Meckel's cartilage will eventually become a component of the lower jaw in both *Xenopus* and humans, however in humans, it will also become part of the middle ear skeletal structures. Nevertheless, using these techniques in *Xenopus* has provided evidence that some WHS-associated genes are required for proper craniofacial development and contribute to the signature craniofacial dysmorphisms seen in WHS patients ([@B75]).

Individuals with WHS display a variety of other symptoms such as microcephaly, heart defects, and renal defects. Whether WHS-associated genes are required for proper development of these organ and tissue systems in relation to WHS still remains unknown. However, many techniques exist in *Xenopus* to study brain, heart, and kidney development. *Xenopus* neurodevelopment has been explored extensively using both *in vitro* and *in vivo* methods ([@B36]; [@B100]). Due to the large size of its growth cones, *X. laevis* is an excellent model to study cytoskeletal dynamics in axon outgrowth and guidance during early development. Moreover, live imaging can be done on both retinal and spinal axonal tracts *in vivo* ([@B36]; [@B100]). Additionally, changes in brain morphology can be quantified simply by measuring the area of the forebrain, midbrain, and hindbrain ([Figure 2B](#F2){ref-type="fig"}), and used as a technique to reflect the microcephaly phenotype associated with WHS ([@B113]; [@B75]).

Congenital heart defects have emerged as the most life-threatening birth defect in newborn patients across different developmental disorders, including WHS ([@B31]; [@B41]). Early heart development is highly conserved between *Xenopus* and mammalian systems, and assays to analyze CHD candidate genes have been created for use in *Xenopus* ([@B101]; [@B31]; [@B50]; [@B20]; [@B41]; [@B106]). The effect of genetic manipulation on heart development can be explored at early tadpole stages using whole-mount *in situ* hybridization, immunohistochemistry with anti-tropomyosin (Tmy) antibody, scanning electron microscopy (SEM), transmission electron microscopy (TEM), or optical coherence tomography (OCT) ([@B101]; [@B50]; [@B20]). These assays help to visualize and detect improperly looped hearts, failed chamber formation, and abnormal structure of the adjacent connective tissue, and can be used to elucidate how mutations of WHS genes lead to CHD ([@B101]; [@B31]).

*In vitro* explant, transplant, and ablation techniques can be used to derive insight into how mutations of genes associated with renal disease affect the progression of kidney development in *Xenopus* ([@B44]). *In vivo* experiments of kidney development range from optogenetic manipulations of physiological parameters (calcium, pH) to characterizations of electrophysiological recordings ([@B65]; [@B44]). Together, *X. laevis* can be used as a powerful system to study how mutations of WHS-associated genes affect the development of multiple tissue and organ systems.

Conclusion {#S4}
==========

*Xenopus laevis* has emerged as an effective model organism for studying human genetic disorders of development, such as WHS. *Xenopus* embryos can be collected in large numbers and are easy to maintain, manipulate, and image. Genetic manipulation strategies are straightforward, allow for the concurrent KD or KO of multiple genes at once, and can be titrated to reduce gene dosage levels similar to that in human patients with WHS. Numerous techniques exist in *Xenopus* to study a variety of tissue and organ systems in order to understand the function of WHS-associated genes during embryonic development. Most importantly, *Xenopus* provides a system in which phenotypes of WHS, including craniofacial abnormalities, brain defects, heart defects, and kidney defects can be easily examined. Moreover, the mechanism by which mutations of WHS-associated genes affects embryonic development can be studied in *Xenopus*, such as changes in NCC migration. Thus, *X. laevis* is an excellent model system for investigating the underlying pathology of WHS, as well as many other human genetic diseases.
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